Archive | Melanoma In The News

Pembrolizumab Combo Shows Positive Response Potential in Melanoma

New data presented at the 2018 American Association for Cancer Research (AACR) Annual Meeting show that a new combination could provide long-term, systemic responses in patients with advanced melanoma.

Read the full story

Posted in Melanoma In The News, Clinical Trials

AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

Cancer often picks up genetic changes that allow it to resist treatment, but this takes time.

Read the full story

Posted in Melanoma In The News, Clinical Trials

AACR 2018: Cancer cells actively fuel growth and metastasis by reprogramming healthy cells

Roswell Park Comprehensive Cancer Center researchers have identified a potential key player promoting cancer progression through changes in the cell environment that are conducive to metastasis.

Read the full story

Posted in Melanoma In The News, Information

AACR 2018: Combination therapy strengthens T cells in melanoma pre-clinical study

A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when given in combination, may enhance the immune system’s ability to kill melanoma tumours deficient in the tumour suppressor gene PTEN.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories